Our Expertise, Your Discovery
Cellomatics Biosciences is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology, Immuno-oncology, Immunology, Inflammation and Respiratory therapeutic areas.
Based in the UK at Colwick Quays Business Park, Nottingham, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies.
Our scientific personnel have expertise in diverse technologies and therapeutic areas. We offer complex cell-based models in the form of monocultures, co-cultures or 3D cultures to replicate in vivo physiology as closely as possible.
With years of experience, our team members have the skills needed to understand your requirements and deliver bespoke, innovative and practical solutions.
Our Therapeutic Expertise
Cellomatics Biosciences has a team of qualified scientists with several years of in vitro bioassay experience. Our strengths lie in our scientific team members, who are experts in bioassay development and validation. Over the years, we have developed, optimised and validated several clinically relevant in vitro disease models within the therapeutic areas described below.
Oncology
Cancer is one of the leading causes of worldwide death in recent years.
Respiratory
Respiratory diseases have been identified to be an immense health…
Immunology
Immunology is the study of the immune response of a body towards antigens.
Inflammation
Chronic or recurrent inflammatory conditions of the colon and small…
Immuno-Oncology
A balanced immune system can perfectly target and remove cancer cells…
How we can help
We offer expert bioassay services tailored to suit your project objectives. During this process, we will provide updates on the progress and be available to discuss findings. The service is modular; if you desire a specific standalone service, please get in touch.
Latest Insights
Read the latest news and views from Cellomatics Biosciences.
